Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRROLIDINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2018/016547
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a novel compound which has an antagonistic activity against CGRP receptors and is useful for the treatment of various diseases associated with CGRP receptors. That is, the present invention relates to a pyrrolidine derivative represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula, W represents a ring, X represents a carbon atom or the like, Y1 to Y4 independently represent a carbon atom or the like, and R1 to R7 independently represent an alkyl group or the like. The compound or a pharmacologically acceptable salt thereof according to the present invention has an excellent antagonistic activity against CGRP receptors and is useful as a therapeutic agent for various diseases associated with CGRP receptors.

Inventors:
KONDO ATSUSHI (JP)
MORITA NAOHIDE (JP)
ISHIKAWA TAKEHIRO (JP)
YOSHIDA MASAKO (JP)
MORIYAMA AKIHIRO (JP)
WANAJO ISAO (JP)
Application Number:
PCT/JP2017/026169
Publication Date:
January 25, 2018
Filing Date:
July 20, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KISSEI PHARMACEUTICAL (JP)
International Classes:
C07D401/14; A61K31/501; A61K31/506; A61P9/00; A61P25/06; A61P43/00; C07D403/12; C07D403/14; C07D405/14
Domestic Patent References:
WO2015161011A12015-10-22
WO2012058645A12012-05-03
Foreign References:
JP2007519729A2007-07-19
JP2010529119A2010-08-26
JP2009544709A2009-12-17
US20110098269A12011-04-28
JP2002506878A2002-03-05
Other References:
LUO , GUANGLIN ET AL.: "Calcitonin gene-related peptide (CGRP) receptor antagonists: Novel aspartates and succinates", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, no. 8, 2012, pages 2912 - 2916, XP055452762, ISSN: 0960-894X
See also references of EP 3459941A4
Attorney, Agent or Firm:
YANAGI, Nobuko et al. (JP)
Download PDF:



 
Previous Patent: ENERGY MANAGEMENT DEVICE

Next Patent: SOLAR CELL ELEMENT